Articles by Park Li-na
Park Li-na
-
APR's Medicube seeks bigger footing in US, Canada
South Korean beauty tech company APR, known for its Medicube brand, announced Wednesday that it has signed a supply agreement with The TJX Companies, a global retail giant operating nearly 5,000 stores across nine countries, including the United States and Canada. With this agreement, Medicube's popular skin care products and AGE-R beauty devices will now be available in TJX-owned stores like TJ Maxx and Marshalls, both well-established names in the North American retail landscape. The prod
Companies Aug. 28, 2024
-
GI Innovation partners with MSD for new cancer drug combination
South Korean biotech company GI Innovation announced Monday a new partnership with Merck Sharp & Dohme, a subsidiary of pharmaceutical company Merck & Co., to test its drug GI-102 in combination with MSD’s anti-PD-1 therapy Keytruda (pembrolizumab) for treating patients with immunotherapy-resistant liver cancer, melanoma and renal cell carcinoma. This marks GI Innovation’s second collaboration with MSD, building on their earlier work for GI-101A. The trial will specifically t
Companies Aug. 26, 2024
-
Celltrion gets European approval for Stelara biosimilar
South Korean biopharmaceutical firm Celltrion announced Monday that it has received the European Commission’s final approval for Steqeyma, a Stelara (ustekinumab) biosimilar used to treat various autoimmune conditions. Steqeyma, or CT-P43, has been approved for use in all indications of reference product Stelara, including plaque psoriasis, psoriatic arthritis and Crohn's disease, following recent approvals in Korea and Canada in June and July, respectively. According to market resear
Companies Aug. 26, 2024
-
Hyundai Steel's low-emission plate push gains momentum
Hyundai Steel, Korea’s second-largest steelmaker, is moving to target the global low-emission steel market amid increasing demand from carmakers moving toward net zero emissions. Hyundai Steel recently signed a memorandum of understanding to supply low-emission steel plates to Tawesco, a leading Czech auto parts manufacturer, and Eusider, an Italian firm specializing in automotive steel plate processing. Both companies supply major European automakers, such as Volkswagen and Stellantis, an
Industry Aug. 25, 2024
-
LG Chem leads growth hormone market with award-winning app
LG Chem is leading the nation's growth hormone market with its award-winning mobile app, EuDi. According to the company, EuDi won the iF Design Award 2024 in the user experience category in March. It was the only pharmaceutical company to win the honor among 521 winners since 2021, in an arena traditionally dominated by consumer electronics, telecoms and automotive sectors. Launched in 2019, the EuDi app was designed to streamline daily injections for children and their caregivers. The app
Technology Aug. 22, 2024
-
Coex to host smart factory trade show in Vietnam next month
The inaugural Automation World Vietnam, a trade show dedicated to smart factory solutions and automation, will be held in Binh Duong Province, north of Vietnam's Ho Chi Minh City, from Sept. 25 to 27, event host Coex said Wednesday. The upcoming event will be the first Automation World expo held outside Korea. AW, hosted by Coex, which operates a convention center under the same name in Seoul, is one of the largest gatherings of the smart factory industry. The Seoul event in March this year
Technology Aug. 21, 2024
-
Amorepacific's Hera debuts in Thailand
South Korean cosmetic giant Amorepacific announced Tuesday that its high-end beauty brand Hera has entered the Thai market. Hera opened its first store in Central Chidlom, a stylish 7-story department store in Bangkok, earlier this month. Over 200 guests, including media representatives and influencers, were invited to celebrate the debut at an event that also introduced the brand’s signature makeup and beauty routines. Alongside the store opening, Hera hosted a pop-up event at Central Chi
Companies Aug. 20, 2024
-
Celltrion eyes top 5 drug maker by 2030
South Korean biopharmaceutical firm Celltrion Pharm unveiled Monday a new vision to become one of South Korea’s top five pharmaceutical companies by 2023. Under Vision 2030, Celltrion Pharm said the company aims to make a quantum leap by enhancing its core business strengths and implementing differentiated growth strategies across its manufacturing, research and sales divisions. Celltrion plans to boost production at its Cheongju plant, which holds Good Manufacturing Practice certification
Companies Aug. 19, 2024
Most Popular
-
1
IMF lowers Korea's 2025 growth outlook to 2%
-
2
Labor Ministry dismisses Hanni harassment case
-
3
North Korean troops fighting alongside Russia, NIS confirms
-
4
Reality show 'I Live Alone' disciplined for 'glorifying' alcohol consumption
-
5
[Herald Interview] How Gopizza got big in India
-
6
Yoon focuses on expanding global solidarity against NK-Russia military ties at APEC, G20 summits
-
7
Japan to hold 1st memorial for Korean forced labor victims at Sado mine
-
8
[KH Explains] Dissecting Hyundai Motor's lobbying in US
-
9
[Kim Seong-kon] Farewell to the vanishing John Wayne era
-
10
[Graphic News] 70% of S. Koreans believe couples can live together without tying the knot: survey